![Elissa Cote](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elissa Cote
Corporate Officer/Principal bij
VISTAGEN THERAPEUTICS, INC.
Vermogen: - $ op 31-07-2026
Profiel
Elissa S.
Cote is Chief Corporate Development Officer at Vistagen Therapeutics, Inc. since 2025.
Formerly, Ms. Cote was Vice President-Marketing & External Relations at Histogenics Corp.
Ms. Cote was Senior Vice President-Global Strategic Marketing at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Ms. Cote completed undergraduate studies at Union College (New York).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-07-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Elissa Cote
| Bedrijven | Functie | Begin |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 23-06-2025 |
Eerdere bekende functies van Elissa Cote
| Bedrijven | Functie | Einde |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Verkoop & Marketing | 01-02-2018 |
| OCUGEN, INC. | Verkoop & Marketing | - |
Opleiding van Elissa Cote
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
45
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Union College (New York)
 Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
